Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Other Accumulated Expenses (2021 - 2026)

Prokidney's (PROK) quarterly Other Accumulated Expenses came in at $2.0 million in Q2 2026, up 62.58% year-over-year from $1.2 million in Q2 2025, and up 42.63% quarter-over-quarter from $1.4 million in Q1 2026.

Analysis

Prokidney (PROK) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Other Accumulated Expenses for 6 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 62.58% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $2.0 million, a 62.58% increase from a year earlier, with the FY2025 full-year figure at $667000.0, down 65.1% from the prior year.
  • Other Accumulated Expenses was $2.0 million for Q2 2026 at Prokidney, up from $1.4 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $2.6 million in Q3 2024 and troughed at $21000.0 in Q4 2022.
  • A 5-year average of $1.3 million and a median of $1.5 million in 2023 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses plunged 85.91% in 2022 and jumped 7214.29% in 2023, its largest moves.
  • Over 5 years, Other Accumulated Expenses stood at $21000.0 in 2022, then jumped by 7214.29% to $1.5 million in 2023, then gained by 24.41% to $1.9 million in 2024, then sank by 65.1% to $667000.0 in 2025, then soared by 194.45% to $2.0 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $2.0 million (Q2 2026), $1.4 million (Q1 2026), and $667000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.96 Mn
Mar 31, 2026 1.38 Mn
Dec 31, 2025 667,000.00
Sep 30, 2025 1.79 Mn
Jun 30, 2025 1.21 Mn
Mar 31, 2025 1.62 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 2.63 Mn
Jun 30, 2024 2.16 Mn
Mar 31, 2024 1.94 Mn
Dec 31, 2023 1.54 Mn
Sep 30, 2023 924,000.00
Jun 30, 2023 542,000.00
Mar 31, 2023 450,000.00
Dec 31, 2022 21,000.00
Sep 30, 2022 537,000.00
Dec 31, 2021 149,000.00